Abbott Laboratories ABT
NYSE ABT
$105.42 -0.10 (-0.09%)
As of: Sep 9, 2026 · 3:30 PM EDT

Abbott Laboratories (ABT) Operating Income Growth (5y) (2014 - 2026)

Analysis

Abbott Laboratories (ABT) Operating Income Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.54 Bn 177.93 Bn 7.27 Bn
2 Intuitive Surgical 124.70 Bn 119.48 Bn 1.96 Bn
3 Medtronic 117.91 Bn 109.09 Bn 6.34 Bn
4 Stryker 105.72 Bn 102.25 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.52 Bn 45.27 Bn 1.35 Bn
7 Alcon 33.89 Bn 32.43 Bn 1.68 Bn
8 Dexcom 32.10 Bn 30.15 Bn 830.00 Mn
9 Steris 21.06 Bn 20.58 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.26 Bn 17.85 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.99%
Mar 31, 2026 -8.60%
Dec 31, 2025 -1.53%
Sep 30, 2025 6.59%
Jun 30, 2025 25.01%
Mar 31, 2025 17.43%
Dec 31, 2024 6.59%
Sep 30, 2024 9.19%
Jun 30, 2024 6.71%
Mar 31, 2024 13.40%
Dec 31, 2023 8.85%
Sep 30, 2023 10.60%
Jun 30, 2023 11.82%
Mar 31, 2023 19.94%
Dec 31, 2022 14.91%
Sep 30, 2022 18.14%
Jun 30, 2022 43.83%
Mar 31, 2022 69.60%
Dec 31, 2021 24.69%
Sep 30, 2021 23.20%